SCHEMBL6668702

SCHEMBL6668702

COc1ccc(C(=O)CC(CC2CCCCC2)C(=O)O)cc1.COc1ccc(C(=O)CC(Cc2ccccc2)C(=O)O)cc1.O=C(CC(Cc1ccccc1)C(=O)O)c1ccc(F)cc1.O=C(CC(Cc1ccccc1)C(=O)O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.46
MCL1 Q07820 1/20 0.46
ALDH1A1 P00352 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.42
CTSS P25774 3/20 0.42
LTA4H P09960 1/20 0.42
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP3 P08254 1/20 0.42
KMO O15229 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SSTR3 P32745 1/20 0.41
CTSL P07711 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6669920 0.99 BCL2L1 (0.47) BCL2L1MCL1ALDH1A1CTSSLTA4H
SCHEMBL6664357 0.93 CTSS (0.44) BCL2L1MCL1ALDH1A1CTSSMMP1
SCHEMBL6667289 0.88 BCL2L1 (0.46) BCL2L1MCL1ALDH1A1L3MBTL1CTSS
SCHEMBL6675156 0.87 NPC1 (0.53) ALDH1A1L3MBTL1KMONPC1RAB9A
SCHEMBL3104440 0.86 ALDH1A1 (0.50) BCL2L1MCL1ALDH1A1L3MBTL1CTSS
SCHEMBL3110072 0.82 LDHA (0.54) BCL2L1MCL1L3MBTL1KMONPC1
SCHEMBL6672055 0.82 KMT2A (0.50) ALDH1A1L3MBTL1KMONPC1RAB9A
SCHEMBL16284887 0.81 NPC1 (0.60) L3MBTL1KMONPC1RAB9A
SCHEMBL3101828 0.81 NPC1 (0.60) L3MBTL1KMONPC1RAB9A
SCHEMBL16284888 0.81 NPC1 (0.60) L3MBTL1KMONPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448181-A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METFORMIN AND A 4-OXOBUTANOIC ACID, AND THE USE THEREOF FOR TREATING DIABETES MERCK PATENT GmbH (DE) 2004-08-25 EP disclosed
WO-2003045368-A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METFORMIN AND A 4-OXOBUTANOIC ACID, AND THE USE THEREOF FOR TREATING DIABETES MERCK PATENT GMBH (DE) 2003-06-05 WO disclosed